Abstract
Since the first case of acquired immunodeficiency syndrome (AIDS) was reported in 1981, AIDS has always been a global health threat and the leading cause of deaths due to the rapid emergence of drug-resistance and unwanted metabolic side effects. Every day in 2007 an estimated 6850 people were newly infected with human immunodeficiency virus (HIV). Over the past 28 years the rapid worldwide spread of AIDS has prompted an intense research effort to discover compounds that could effectively inhibit HIV. The development of new, selective and safe inhibitors for the treatment of HIV, therefore, still remains a high priority for medical research. To the best of our knowledge, the indole derivatives have been considered as one class of promising HIV-1 inhibitors, such as delavirdine approved by the Food and Drug Administration (FDA) in 1997 for use in combination with other antiretrovirals in adults with HIV infection. In this review we focus on the synthesis and anti-HIV-1 activity of indole derivatives, in the meantime, the structure – activity relationship (SAR) for some derivatives are also surveyed. It will pave the way for the design of indole derivatives as anti- HIV-1 drugs in the future.
Keywords: Indole, synthesis, acquired immunodeficiency syndrome, human immunodeficiency virus, inhibitor, structure, –, activity relationship
Current Pharmaceutical Design
Title: Developments of Indoles as Anti-HIV-1 Inhibitors
Volume: 15 Issue: 18
Author(s): Hui Xu and Min Lv
Affiliation:
Keywords: Indole, synthesis, acquired immunodeficiency syndrome, human immunodeficiency virus, inhibitor, structure, –, activity relationship
Abstract: Since the first case of acquired immunodeficiency syndrome (AIDS) was reported in 1981, AIDS has always been a global health threat and the leading cause of deaths due to the rapid emergence of drug-resistance and unwanted metabolic side effects. Every day in 2007 an estimated 6850 people were newly infected with human immunodeficiency virus (HIV). Over the past 28 years the rapid worldwide spread of AIDS has prompted an intense research effort to discover compounds that could effectively inhibit HIV. The development of new, selective and safe inhibitors for the treatment of HIV, therefore, still remains a high priority for medical research. To the best of our knowledge, the indole derivatives have been considered as one class of promising HIV-1 inhibitors, such as delavirdine approved by the Food and Drug Administration (FDA) in 1997 for use in combination with other antiretrovirals in adults with HIV infection. In this review we focus on the synthesis and anti-HIV-1 activity of indole derivatives, in the meantime, the structure – activity relationship (SAR) for some derivatives are also surveyed. It will pave the way for the design of indole derivatives as anti- HIV-1 drugs in the future.
Export Options
About this article
Cite this article as:
Xu Hui and Lv Min, Developments of Indoles as Anti-HIV-1 Inhibitors, Current Pharmaceutical Design 2009; 15 (18) . https://dx.doi.org/10.2174/138161209788489168
DOI https://dx.doi.org/10.2174/138161209788489168 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
T-Cell Zeta Chain Expression, Phosphorylation and Degradation and their Role in T-Cell Signal Transduction and Immune Response Regulation in Health And Disease
Current Signal Transduction Therapy A Novel Method for Preparation of Linezolid, (S)-N-((3-(3-Fluoro-4- Morpholinophenyl)-2-Oxo-5-Oxazolidinyl) Methyl) Acetamide
Letters in Organic Chemistry Editorial [Hot Topic: Nucleoside and Nucleotide Therapeutics: Recent Targets in Medicinal Chemistry (Guest Editor: Claire Simons)]
Current Topics in Medicinal Chemistry Isoniazid Induced Convulsions at Therapeutic Dose in an Alcoholic and Smoker Patient
Current Drug Safety Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Mini-Reviews in Organic Chemistry Radical Releasing Anti-tuberculosis Agents and the Treatment of <i>Mycobacterial Tuberculosis</i> Infections - An Overview
Mini-Reviews in Medicinal Chemistry Nitric Oxide and the Regulation of Apoptosis in Tumour Cells
Current Pharmaceutical Design Challenges and Opportunities for Bacterial Vaccine Development in the 21<sup>st</sup> Century
Current Pharmaceutical Biotechnology Review of the Phytochemistry and Biological Activity of Cissus incisa Leaves
Current Topics in Medicinal Chemistry Therapeutic Potential of Indole Derivatives as Anti-HIV Agents: A Mini-review
Current Topics in Medicinal Chemistry Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Uropathogenic Escherichia coli Mediated Urinary Tract Infection
Current Drug Targets Molecular Tools for Typing and Branding the Tubercle Bacillus
Current Molecular Medicine HLA-E and HLA-E-Bound Peptides: Recognition by Subsets of NK and T Cells
Current Pharmaceutical Design Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design
Current Medicinal Chemistry Glutamate-Based Drugs for the Treatment of Clinical Depression
Central Nervous System Agents in Medicinal Chemistry Mycobacterium tuberculosis Biology Revealed by Proteome Profiling and Integration of Multi-omics Data—Proteomics Insight into M. tuberculosis Systems Biology
Current Proteomics Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy
Current HIV Research Periodic Correlation Structures in Bacterial and Archaeal Complete Genomes
Current Bioinformatics